Envista Holdings Corporation Common Stock (NVST)

Turnaround

FairStock Score: 41/100 — MIXED

Key Financials

Current Price$23.6
Market Cap$3.8B
P/E Ratio40.69
ROE3.06%
Dividend Yield—%
SectorHealthcare

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Envista is a $3.6 billion dental-products company. The filed record shows why FairStock's Lynch category is TURNAROUND: it returned to profit after a loss within the last three years. In FY2024 (period ended 2024-12-31), revenue was $2.5B but net income was -$1.1B; in FY2023 (period ended 2023-12-31), net income was -$100.2M. By FY2025 (period ended 2025-12-31), revenue was $2.7B and net income turned positive at $47.0M. More recently, in fiscal Q2 2026 (quarter ended 2026-07-03), revenue was $730.5M and net income $53.7M, or diluted EPS $0.33; that follows fiscal Q1 2026 (quarter ended 2026-04-03) net income of $38.7M, or $0.23. So the profit recovery is real and accelerating. FairStock's Piotroski F-score is 8/9, and TTM free cash flow is $248.1M, a 6.8% FCF yield, which supports the idea that cash generation is healthier than earnings alone suggest. But quality is not yet proven: FairStock's ROE of 3.06% and ROCE of 3.23% are thin; its Altman Z-score of 1.20 signals balance-sheet risk; D/E of 0.52 is manageable but not fortress-like. Valuation is mixed. At the $22.65 close on 2026-10-13, P/B of 1.18, EV/EBITDA of 9.74 and FCF yield of 6.8% look reasonable, but P/E of 39.05 is high, and Graham Number of $15.81 implies a negative -43.26% margin of safety. The market is paying for a successful turnaround. I would want several more clean quarters and steady margins before calling this a durable moat business.

In plain English: Envista makes dental products such as implants, equipment, and consumables. The business looks like a turnaround: it lost money in fiscal 2023 and fiscal 2024 but has made profits in recent fiscal 2026 quarters, and cash flow is positive. At $22.65 on 2026-10-13, the price looks expensive compared with recent profit and asset value, though not obviously expensive relative to cash flow.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-07-03) · fiscal Q1 2026 10-Q (period ended 2026-04-03) · fiscal Q3 2025 10-Q (period ended 2025-09-26) · fiscal Q2 2025 10-Q (period ended 2025-06-27) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer